RCT in 69 participants after abortion or pregnancy loss at 16-20 weeks: single-dose cabergoline 1 mg vs placebo cut any breast symptoms on day 4 (50.0% vs 88.2%, P<.001); significant bother was a secondary outcome (3.1% vs 20.6%).
RCTn = 69
Henkel et al. Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss: A Randomized Controlled Trial